The Wisdom of Sun Tzu’s Art of War in China’s Anti-Epidemic War
Vol 6, Issue 6, 2023
VIEWS - 37 (Abstract) 48 (PDF)
Abstract
Chinese government implemented various measures such as imposing penalties on those responsible for the epidemic, rewarding heroes,
and improving medical staff treatment. China’s strategy focused on immediate action and preventing prolonged warfare, reflecting Sun Tzu’s
principles. The government prioritized quick response, containment, and mobilization of resources to control the outbreak. China also shared
its experience and achievements with the world, emphasizing the importance of international cooperation. The use of health codes and nu_x005fcleic acid testing played a crucial role in identifying and managing the spread of the virus. Logistics and material support were prioritized to
ensure the well-being of the population. The limitations and challenges faced in applying traditional war principles to a hidden enemy like the
virus are also discussed. Overall, China’s approach to the pandemic reflects a combination of strategic thinking, adaptability, and international collaboration.
Keywords
Full Text:
PDFReferences
1. [1] Chung, C. K. L., Xu, J., & Zhang, M. (2020). Geographies of Covid-19: how space and virus shape each other. Asian Geographer,
2. 37(2), 99-116.
3. [2] Döring, N. (2020). How is the COVID-19 pandemic affecting our sexualities? An overview of the current media narratives and re_x005fsearch hypotheses. Archives of sexual behavior, 49(8), 2765-2778.
4. [3] Hagström, L., & Gustafsson, K. (2021). The limitations of strategic narratives: The Sino-American struggle over the meaning of
5. COVID-19. Contemporary Security Policy, 42(4), 415-449.
6. [4] Jiang, J., Han, P., Huang, X., et al. (2022). Post-traumatic growth experience of first-line emergency nurses infected with COVID-19 during the epidemic period—A qualitative study in Shanghai, China. Frontiers in Public Health, 10, 1015316.
7. [5] Kumari, M., Lu, R. M., Li, M. C., et al. (2022). A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. Journal of biomedical science, 29(1), 1-36.
8. [6] Lionel Giles. (2018). Sūnzǐ: The Art of War. Available from: https://pages.ucsd.edu/ ~dkjordan/chin/Suentzyy/Suentzyy01.html.
9. [7] Luo, H., Liu, J., Li, C., et al. (2020). Ultra-rapid delivery of specialty field hospitals to combat COVID-19: Lessons learned from
10. the Leishenshan Hospital project in Wuhan. Automation in Construction, 119, 103345.
11. [8] Mahmud, A., Ding, D., & Hasan, M. M. (2021). Corporate social responsibility: Business responses to Coronavirus (COVID-19)
12. pandemic. SAGE open, 11(1), 2158244020988710.
13. [9] Redeker, D., Bernardes, M., Davidian, G., et al. (2022). Mapping Policy Responses to the Covid-19 Misinfodemic. IPW Working
14. Paper.
15. [10] Sahin, A. R., Erdogan, A., Agaoglu, P. M., et al. (2020). 2019 novel coronavirus (COVID-19) outbreak: a review of the current
16. literature. EJMO, 4(1), 1-7.
17. [11] Shaw, R., Kim, Y. K., & Hua, J. (2020). Governance, technology and citizen behavior in pandemic: Lessons from COVID-19 in
18. East Asia. Progress in disaster science, 6, 100090.
19. [12] Wang, X., Ma, T., Zhang, W., & Chu, Q. (2022). Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis. Chinese Medicine, 17(1), 1-16.
20. [13] Wu, F., Hu, Q., Zhu, C., Wang, H., Yu, Q., & Sun, H. (2021). New structural economic analysis of anti-COVID-19 pandemic model of BEST region. International Journal of Environmental Research and Public Health, 18(15), 7822.
21. [14] Xia, S., Huang, H., & Zhang, D. (2022). Framing as an Information Control Strategy in Times of Crisis. Journal of East Asian
22. Studies, 1-25.
23. [15] Xing, C., & Zhang, R. (2021, January). COVID-19 in China: responses, challenges and implications for the health system. In
24. Healthcare (Vol. 9, No. 1, p. 82). MDPI.
DOI: https://doi.org/10.18686/ijmss.v6i6.4040
Refbacks
- There are currently no refbacks.
This site is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.